Rapid Responses to:

PRACTICE:
N M Rahman, R J O Davies, and F V Gleeson
Investigating suspected malignant pleural effusion
BMJ 2007; 334: 206-207 [Full text]
*Rapid Responses: Submit a response to this article

Rapid Responses published:

[Read Rapid Response] Don't forget surgical techniques
michael poullis   (27 January 2007)
[Read Rapid Response] tuberculous pleural effusion can simulate malignant pleural effusion
oscar,m jolobe   (27 January 2007)
[Read Rapid Response] VATS remains the gold standard for investigation of malignant pleural effusion
Loic Lang-Lazdunski, John E Pilling   (31 January 2007)

Don't forget surgical techniques 27 January 2007
 Next Rapid Response Top
michael poullis,
consultant cardiothoracic surgeon
ctc liverpool l14 3pe

Send response to journal:
Re: Don't forget surgical techniques

Rahman et al in their article on Investigating suspected malignant pleural effusion, unfortunately mentions medical thoracopcopy as the only diagnostic and therapeutic intervention should needle aspiration or closed pleural biopsy fail. This unfortunately may not be best practice for all patients, and certainly does not constitute a comprehensive assessment review on how to manage this often difficult condition.

Unfortunately medical thoracoscopy is only useful for simple non loculated effusions with minimal visceral lung involvement, an important fact that the authors failed to mention. Failure to appreciate this could result in a failed procedure at best, but unfortunately could also result in significant pulmonary parenchymal damage. In addition pleurodesis will not work in cases with significant visceral lung involvement.

Surgical thoracoscopy enables pleural loculations to be broken down, and allows assessment of the advisability of talc instillation. Unnecessary talc instillation in a case that will clearly never work unfortunately can lead to formation of an empyema.

In summary these sometimes seemingly simple, but often complicated cases should be discussed with a thoracic surgeon. In addition unaudited “I’ve been trained so I’ll have a go at medical thorascopcopy” should be discouraged for the sake of putting the patient first.

Competing interests: None declared

tuberculous pleural effusion can simulate malignant pleural effusion 27 January 2007
Previous Rapid Response Next Rapid Response Top
oscar,m jolobe,
retired geriatrician
1 The Lodge, 842 Wilmslow Road, didsbury, manchester, M20 2RN

Send response to journal:
Re: tuberculous pleural effusion can simulate malignant pleural effusion

A blood stained pleural effusion falls into the category cited in the title, namely, suspected malignant pleural effusion(1). In a study dealing with "clinical implications of appearance of pleural fluid at thoracentesis" 47% of 59 "bloody"(ie dark red, similar to blood)pleural effusions were attributable to malignancy, and, among the rest of the bloody pleural effusions were two instances of tuberculous pleural effusion(2). In countries with a high prevalence of tuberculosis malignancy is still the commonest cause of bloody pleural effusion but the next most common causes are tuberculosis and trauma(3). Accordingly in the absence of associated stigmata of malignancy, even pleural effusion whose outward apparance is highly suggestive of malignancy should be considered to be of potentially tuberculous aetilogy, and appropriate tests should be instigated if initial investigations are not confirmatory of malignancy. In this context appropriate tests for a tuberculous aetiology include, not only closed biopsy(with histology and culture), as mentioned by the authors(1), but also quantification of interferon gamma in the pleural fluid(4). In the context of tuberculous pleural effusion the latter parameter is associated with sensitivities and specificities of the order of 90-100%(4)(5), highly comparable results being also generated by the adenosine deaminase(ADA) content of the pleural fluid(4)(5). Given these opportunities to make a rapid diagnosis of tuberculous pleural effusion, whenever the diagnosis of suspected malignant effusion remains in doubt, especially if the patient is from a high-risk population, there should be minimum delay in initiating tests for a tuberculous aetiology, and these tests should include interferon gamma and ADA. References (1) Rahman NM., Davies RJO., Gleeson FV Investigating suspected maliganant pleural effusion BMJ 2007:334:206-7 (2)Villena V., Lopez-Encuentra A., Garcia-Lujan R et al Clinical implications of appearance of pleural fluid at thoracocentesis Chest 2004:125:156-9 (3)Onadeko BO Haemorrhagic pleural effusion in Nigerians Trop Geogr Med 1979:31:57-61 (4)Aoe K., Hiraki A., Murakami T et al Diagnostic significance of interferon-gamma in tuberculous pleural effusions Chest 2003:123:740-44 (5)Gupta UA., Chhabra SK Diagnosing tubercular pleural effusions Chest 2005:127:1078-9 References

Competing interests: None declared

VATS remains the gold standard for investigation of malignant pleural effusion 31 January 2007
Previous Rapid Response  Top
Loic Lang-Lazdunski,
consultant thoracic surgeon
Guy's hospital, London,
John E Pilling

Send response to journal:
Re: VATS remains the gold standard for investigation of malignant pleural effusion

We read with interest the article by Rahman and colleagues from Oxford.

We were surprised that video-assisted thoracoscopic surgery (VATS) is not mentioned in the article. For more than 15 years VATS has been the cornerstone of investigation and palliation of malignant pleural effusion in those fit for general anaesthetic:

Complex loculated effusions can be evacuated and the pleural cavity debrided appropriately.

The systematic examination of the mediastinum, pericardium and diaphragm as well as the visceral pleura and underlying lung is easily and safely performed. Multiple targeted pleural biopsies can be performed as well as biopsies of mediastinal nodes as required.

The expansion of the lung in response to positive pressure ventilation determines the appropriate method of palliation. If there is apposition of the visceral and parietal pleura talc pleurodesis is the method of choice, where this does not occur talc is detrimental and potentially leads to empyema. In the vast majority of series surgical talc insufflation has been shown to provide superior palliation to talc slurry.

Lastly, as a thoracic surgeon operating on a large volume of patients with malignant mesothelioma, VATS represents an excellent staging tool and determinant of the best surgical option for those patients (palliative talc pleurodesis, pleurectomy/decortication or extrapleural pneumonectomy).

Competing interests: none